logo
logo

Hcap Partners Invests In Dfw Neuropathy

Hcap Partners Invests In Dfw Neuropathy

09/27/22, 12:49 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgfrisco
Industry
medical
biotechnology
health care
HCAP Partners, a California-based private equity firm and nationally recognized impact investor, today announced its investment in DFW Neuropathy, a neuropathy treatment company based in North Texas that specializes in Combination Electroanalgesia Treatment (CET) to heal or reverse peripheral neuropathy. Terms of the investment were not disclosed. Baymark Partners, a Dallas-based private equity firm, led the transaction.

Company Info

Company
DFW Neuropathy
Location
denton
frisco, colorado, united states
Additional Info
The company specializes in Combination Electroanalgesia Treatment to heal or reverse peripheral neuropathy that commonly results from diabetes, impact injuries, or medication damaging the peripheral nerves. The firm seeks to invest $3 million to $25 million in established businesses generating between $10 million and $100 million in revenues in the healthcare, software, services, and manufacturing industries. "DFW Neuropathy is providing a positive impact on the quality of life of its patients and we look forward to working with the company to make this treatment more widely accessible." DFW Neuropathy is a growing neuropathy treatment company with four locations in the Dallas­­­­­­­­­­­­­­­­­­–Fort Worth metroplex. Founded in 2010, DFW Neuropathy is a health clinic based in North Texas specializing in the treatment of all types of neuropathy and musculoskeletal pain and ailments.

Related People